IHT Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,806
Closed -$201K 1127
2024
Q3
$201K Buy
+2,806
New +$198K 0.01% 1090
2024
Q1
Sell
-8,915
Closed -$475K 1035
2023
Q4
$475K Sell
8,915
-384
-4% -$18.7K 0.02% 616
2023
Q3
$462K Buy
9,299
+8
+0.1% +$447 0.02% 582
2023
Q2
$553K Buy
9,291
+309
+3% +$17.6K 0.03% 511
2023
Q1
$509K Sell
8,982
-658
-7% -$42.2K 0.03% 492
2022
Q4
$716K Buy
9,640
+112
+1% +$7.63K 0.05% 382
2022
Q3
$568K Buy
+9,528
New +$574K 0.04% 421
2022
Q2
Sell
-3,418
Closed -$252K 767
2022
Q1
$252K Buy
3,418
+10
+0.3% +$695 0.02% 631
2021
Q4
$246K Sell
3,408
-36
-1% -$2.61K 0.02% 682
2021
Q3
$264K Buy
3,444
+490
+17% +$39.3K 0.02% 637
2021
Q2
$229K Buy
+2,954
New +$210K 0.01% 816

Other funds holding GMED

IHT Wealth Management's GMED Position: Q4 2024 in Review

IHT Wealth Management sold out of Globus Medical (GMED) in Q4 2024, closing a stake of 2,806 shares — an estimated $201K sold.

IHT Wealth Management first reported a position in GMED in Q2 2021 and held it in 11 quarters. The position peaked at $716K in Q4 2022. 500 funds tracked by Wall St. Rank hold GMED as of Q4 2024.

  • IHT Wealth Management reported no remaining Globus Medical position as of Q4 2024 after selling out during the quarter.
  • IHT Wealth Management sold 2,806 Globus Medical shares in Q4 2024, an estimated $201K.
  • IHT Wealth Management first reported a position in Globus Medical in Q2 2021 and held it in 11 quarters.
  • IHT Wealth Management's Globus Medical position peaked at $716K in Q4 2022.
  • 500 funds tracked by Wall St. Rank held Globus Medical as of Q4 2024.

Based on IHT Wealth Management's 13F filing for Q4 2024, filed 14 Feb 2025.